Advertisements



Genentech submits sNDA to FDA for Venclexta

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 12th, 2018

Roche submits sNDA to FDA for Venclexta with Gazyva

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytMar 7th, 2019

ViiV Healthcare submits sNDA to FDA for HIV treatment Cabenuva

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 24th, 2021

Amgen submits sNDA for Otezla for adults with mild to moderate plaque psoriasis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 22nd, 2021

Roche announces FDA acceptance of Genentech Esbriet sNDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 21st, 2021

Ocular Therapeutix submits Dextenza sNDA to FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 22nd, 2020

Genentech submits sBLA to FDA for Tecentriq/Avastin combo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 27th, 2020

Genentech reports data from two Phase III Venclexta studies in leukemia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 8th, 2019

GlaxoSmithKline owned ViiV Healthcare submits Dovato sNDA to FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2019

Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx

Puma Biotech (PBYI) files an sNDA for the nod of Nerlynx in combination with Xeloda to treat patients with HER2-positive metastatic breast cancer, having failed two or m.....»»

Category: dealsSource: nytJul 2nd, 2019

Puma Biotechnology submits sNDA to FDA for neratinib/capecitabine combo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 1st, 2019

Amarin submits sNDA to FDA for new Vascepa indication for cardiovascular risk

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 28th, 2019

Dova submits sNDA for DOPTELET for chronic ITP treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 4th, 2018

Ocular Therapeutix submits sNDA to FDA for Dextenza

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 10th, 2019

The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks The following biotech stocks hit 52-week highs Jan. 10:  read more.....»»

Category: blogSource: benzingaJan 11th, 2019

The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA

Here's a r.....»»

Category: earningsSource: benzingaJan 11th, 2019

Ocular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza

Ocular (OCUL) files an sNDA to the FDA for expanding the label of its eye drug, Dextenza, to treat ocular inflammation post ophthalmic surgery. .....»»

Category: worldSource: nytJan 11th, 2019

Genentech submits sBLA to FDA for Kadcyla

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2019

Skyhawk’s latest biopharma collaboration is worth up to $1.8B

Skyhawk has also previously unveiled partnerships with the likes of Vertex Pharmaceuticals Inc., Bristol Myers Squibb, Takeda Pharmaceuticals, Genentech and Biogen Inc......»»

Category: topSource: bizjournalsApr 23rd, 2024

US Submits "Assurances" To UK Govt Over Assange Extradition 

US Submits 'Assurances' To UK Govt Over Assange Extradition  Via .....»»

Category: smallbizSource: nytApr 18th, 2024

Genentech to cut 3% of workforce across company

The job cuts are among several thousand positions eliminated across the drug industry over the past couple of years......»»

Category: topSource: bizjournalsApr 10th, 2024